National

Amrita varsity to launch insulin pump

LN Revathy Coimbatore | Updated on January 23, 2018 Published on April 17, 2015




The commercial launch of Amrita Insulin Pump, designed and developed by researchers in the three Amrita campuses at Amritapuri, Coimbatore and Kochi, is expected soon.

“Negotiations are in an advanced stage with an industry partner for production and potential commercialisation of this automated pump, which was recently awarded a patent by the United States Patent and Trademark Office,” a spokesperson of Amrita University in Coimbatore told BusinessLine.

Stating the development of the pump was made possible through financial support from the Department of Science and Technology, Government of India, and seamless integration of experts in the three Amrita campuses, the spokesperson said the pump will have features not found in other designs.

Insulin pumps are normally expensive, costing around ₹2.5 lakh, but at Amrita, we have worked to develop a less expensive pump, the spokesperson added.

Mechanical engineers, electronics engineers, endocrinologists, biochemists, computer scientists and those familiar with regulatory aspects of biomedical devices are said to have been involved in developing the prototype of the pump for close to four years.

Published on April 17, 2015

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.